REVIEW
Add like
Add dislike
Add to saved papers

New dimensions to poliomyelitis.

About 22% of persons who suffer from acute paralytic poliomyelitis 20 to 30 years ago and were fully rehabilitated with maximal functional recovery began to experience new symptoms termed "Post-polio Sequelae" (PPS). These include unaccustomed fatigue, weakness in muscles previously affected or apparently unaffected, new joint pains, respiratory difficulties and intolerance to cold. Predictors for PPS are development of acute attack of paralytic polio before 10 years of age, involvement of all four limbs and having needed a ventilator during acute stage. The functional decompensation in PPS is presumed to be due to loss of normal neurones by aging and by metabolic fatigue of stressed neurones over passing years. Joint deformities due to muscular imbalance are also responsible for some of the symptoms. Treatment consists of reassurance and use of assistive devices and assistive exercises. The extent of problem of PPS is not known in India.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app